APA (7th ed.) Citation

Yanzhi Wan, Keqin Tan, & Hong Zhu. (2024). QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: A case report. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yanzhi Wan, Keqin Tan, and Hong Zhu. QL1604 Combined with Bevacizumab as an Innovative First-line Treatment for HCC Patient with Extensive Metastasis Who Showed Remarkable Effect: A Case Report. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Yanzhi Wan, et al. QL1604 Combined with Bevacizumab as an Innovative First-line Treatment for HCC Patient with Extensive Metastasis Who Showed Remarkable Effect: A Case Report. Frontiers Media S.A., 2024.